The incidence of hypoglycaemia was higher with glimepiride than with linagliptin ( @ vs. @ % ; p < @ ) ; after performing sensitivity analyses by excluding events during dose escalation ( weeks@-@ ) , this difference remained significant ( weeks@-@ : @ vs. @ % ; p < @ ) .